Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Specialties
Publications
Articles from Nancy Dvorin:
Read all from this author
Perspective & Commentary

Digital Edition: Market Pathways June-July 2026

  • 2026-06-01 00:00:00.0
  • Nancy Dvorin
  • Market Pathways

Leaning in to the potential of AI to transform medtech regulatory affairs without creating an overreliance on the technology. Leading European regulatory experts discuss how MDR might be restructured and when it could occur; until it happens, a decline in MDR/IVDR submissions leads notified bodies to cut staff. FDA unveils what it agreed to in MDUFA VI talks; companies caught off guard by CMS proposal to end simplified path to add-on payments for breakthrough devices.

Read Article